Subscribe
1heals
1heals / iStockphoto.com
29 November 2017Big Pharma

Life sciences industry calls for Brexit transition period

The EU and UK must make progress in Brexit negotiations “as soon as possible”, according to the associations that represent the European and British life sciences industry.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
After Brexit: new directions for clinical trials
10 October 2017   If the UK government changes the rules for clinical trials after Brexit, the regimes in the UK and the EU will diverge and possibly make trials more complex and costly, as Rachel Bradley of Penningtons Manches reports.
Big Pharma
Big pharma companies react to ‘Brexit’
28 June 2016   Following the result of the UK’s referendum on membership of the EU, pharmaceutical companies have yet to find out how this will affect their businesses.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Big Pharma
After Brexit: new directions for clinical trials
10 October 2017   If the UK government changes the rules for clinical trials after Brexit, the regimes in the UK and the EU will diverge and possibly make trials more complex and costly, as Rachel Bradley of Penningtons Manches reports.
Big Pharma
Big pharma companies react to ‘Brexit’
28 June 2016   Following the result of the UK’s referendum on membership of the EU, pharmaceutical companies have yet to find out how this will affect their businesses.

More on this story

Big Pharma
After Brexit: new directions for clinical trials
10 October 2017   If the UK government changes the rules for clinical trials after Brexit, the regimes in the UK and the EU will diverge and possibly make trials more complex and costly, as Rachel Bradley of Penningtons Manches reports.
Big Pharma
Big pharma companies react to ‘Brexit’
28 June 2016   Following the result of the UK’s referendum on membership of the EU, pharmaceutical companies have yet to find out how this will affect their businesses.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB